Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of D2D001 for oral and nasal HSV-1 infection
2008-003953-34Phase 2Completed
- Sponsor
- D2 Derma
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of D2D001 in Herpes simplex virus type 1 infection (3 arms), sponsored by D2 Derma. Primary endpoint: Response rate at visit 3. Started Oct 2009; status: completed.
02
Drugs
D2D001
03
Conditions
Herpes simplex virus type 1 infection
Beyond the preview
Go deeper on 2008-003953-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003953-34.